Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

83.08 -1.16 (-1.38%)
Official Closing Price Updated: 7:00 PM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Edwards Lifesciences

< Previous 1 2 3 4 5 6 Next >
News headline image
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Announces CFO Transition Plan
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Reports Third Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From Rosen Law Firm
Via Business Wire
News headline image
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.